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A combined phytochemical, crystallographic and biological study of Worsleya procera roots 
was performed. Fifteen alkaloids were identified by gas chromatography mass spectrometry 
(GC-MS) and seven of them were isolated. The structures of the alkaloids were elucidated by 
spectroscopic methods, and a detailed crystallographic study of tazettine was carried out. The 
isolated alkaloids and the obtained extracts were tested in vitro against Plasmodium falciparum 
(3D7 and K1 strains) and human hepatocarcinoma cells (HepG2) to assess their antiplasmodial 
and cytotoxic effects, respectively. One of the isolated alkaloid derivatives, lycorine, exhibited 
antiplasmodial activity against both sensitive (3D7) and resistant (K1) parasite strains in the low 
micromolar range (half-maximal sample inhibitory concentration (IC50) values of 2.5 and 3.1 μM, 
respectively) and displayed a low cytotoxicity profile, with a selectivity index greater than 100. 
Our findings indicate that lycorine is a hit for antimalarial drug discovery.
Keywords: isoquinolinic alkaloids, Amaryllidaceae, Plasmodium falciparum, lycorine, 
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Introduction
Malaria is one of the most relevant infectious diseases 
throughout the world. For decades, global efforts towards 
malaria eradication reflected in a yearly decrease in 
cases and mortality rates. Since 2016, however, the rate 
of malaria infections is rising due to resistance in both 
the parasite and the mosquito vectors to antimalarial 
drugs and insecticides, respectively.1 Artemisinin-based 
combination therapies (ACTs), employing artemisinin 
and its derivatives (dihydroartemisinin, artemether and 
artesunate), remain as the standard treatment against 
falciparum malaria. However, the emergence and spread 
of resistance are constant threats, as cases of parasite 
resistance to ACTs have been reported as early as 
2008.2 Hence, the efficiency of drugs in use has been 
declining, despite investment from organizations such 
as the Bill and Melinda Gates Foundation and national 
governments. Unquestionably, there is a demand for new 
and effective drugs for malaria treatment.
Natural products play an important role in the 
discovery process of new drugs.3 Brazilian biodiversity 
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has an enormous potential for the discovery of new 
natural products endowed with innovative molecular 
scaffolds and activity against various diseases.4-7 In this 
sense, plants of the Amaryllidaceae family are promising 
sources of bioactive molecules.8-20 Comprising more 
than 1600 species worldwide, the Amaryllidaceae family 
is distinguished by the production of isoquinolinic 
alkaloids, a privileged scaffold responsible for most of the 
biological activities observed in these plants. This kind 
of alkaloids is specifically found in the Amaryllidoideae 
subfamily species. In Brazil, according to Rio de Janeiro’s 
Botanical Garden,21 142 species of Amaryllidaceae have 
been described, of which 64 are endemic and some are 
endangered, as is the case of Worsleya procera (Lem.) 
Traub,22 the only representative of the genus Worsleya.18,23-26 
This species occurs exclusively in the State of Rio de 
Janeiro (Brazil) and no phytochemical study has been 
reported for this species so far.
In this work, we performed a combined strategy 
including phytochemical, crystallographic and biological 
studies to better characterize the isolated alkaloids from 
Worsleya procera. We investigated the roots’ extracts for 
their chemical composition, identified fifteen alkaloids 
by gas chromatography mass spectrometry (GC-MS), 
and isolated seven derivatives. Next, we conducted 
crystallographic studies and solved the molecular structure 
of tazettine at high resolution. All isolated alkaloids 
and the obtained extracts were tested in vitro for their 
antiplasmodial potency against Plasmodium falciparum, as 
well as for their cytotoxic effect in human hepatoma cells 
(HepG2). The most potent alkaloid derivative, lycorine, is 
a low micromolar inhibitor of both sensitive and resistant 




Roots of Worsleya procera were collected in Petropolis 
city (State of Rio de Janeiro, Brazil) in July 2014. The 
plant was collected in an area of environmental protection 
(22°32’38.7”S 43°10’11.8”W); therefore, an authorization 
for sampling was issued by the proper regulatory agencies 
(Sistema de Autorização e Informação em Biodiversidade 
(SISBIO) No. 41717). The sample was authenticated 
by Dr Julie H. A. Dutilh from University of Campinas 
(Unicamp, Campinas city, Brazil). A specimen voucher 
(No. 35307) was deposited in the Herbarium VIES of the 
Department of Botany of the Federal University of Espírito 
Santo (Vitória city, Brazil).
Equipment
The GC-MS spectra were obtained on a GC-17A 
Shimadzu CG-MS QP 5000 operating in the EI mode at 70 eV 
using a DB5 MS column (30 m × 0.25 mm × 0.25 μm). 
The temperature program was as it follows: 100-180 °C 
at 15 °C min-1, 1 min hold at 180 °C, then 180-300 °C 
at 5 °C min-1 and 10 min hold at 300 °C. The injector 
temperature was 280 °C. The flow rate of carrier gas 
(helium) was 0.8 mL min-1 and the split ratio was 1:20.
The alkaloids were identified by comparing their 
GC-MS spectra and Kovats retention indices (RI) with our 
library database. This library has been regularly updated 
with alkaloids isolated and unequivocally identified via 
physical and spectroscopic means.27-29 Mass spectra were 
deconvoluted using AMDIS 2.64 software (NIST) (WA, 
USA) and RIs recorded using a standard n-hydrocarbon 
calibration mixture (C9-C36). The proportion of individual 
components in the alkaloid fractions is expressed as a 
percentage of total alkaloid content. GC-MS peak areas 
are dependent on the concentration of the injected alkaloid, 
as well as the intensity of its mass spectral fragmentation. 
Although the data given in Table 1 are not representative 
of a validated alkaloid quantification method, they can be 
used for a relative comparison purpose.
Nuclear magnetic ressonance (NMR) spectra were 
recovered in a Varian 400 MHz instrument using 
CDCl3 (CD3OD for compound 11) as a solvent and 
tetramethylsilane (TMS) as the internal standard. Chemical 
shifts were reported in  units (ppm) and coupling constants 
(J) in Hz.
Silica gel (120 g, mesh 70/90 μm) was used for 
vacuum liquid chromatography column (VLCC), and silica 
gel 60 F254 Macherey-Nagel for analytics and prep. Spots 
on chromatograms were detected under UV light (254 nm) 
and by Dragendorff’s reagent stain.
Extraction and isolation of alkaloids
Fresh roots (6.7 Kg) of Worsleya procera were crushed 
and exhaustively extracted with MeOH (100% v/v) at 
room temperature for 48 h, and the combined macerate 
was filtered and evaporated to dryness under reduced 
pressure. The crude extract of roots (146.2 g) was acidified 
to pH 2 with diluted sulphuric acid (H2SO4) and extracted 
with diethyl ether (Et2O) (3 × 150 mL) to remove neutral 
material. The aqueous solution was basified with 25% 
ammonia (NH3) up to pH 10 and extracted with n-hexane 
(18 × 250 mL) to give extract A (2.9368 g). Another 
extraction using ethyl acetate (EtOAc) (18 × 350 mL) gave 
extract B (6.9987 g), and the last extraction using EtOAc 
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and methanol (MeOH) (3:1, 3 × 200 mL) gave extract C 
(7.7210 g). 
Extract A yielded lycorine (11, 42.3 mg) by spontaneous 
precipitation. The supernatant was subjected to a VLCC 
column (Ø: 3 cm) using silica gel (120 g, mesh 70/90 μm) 
eluting with n-hexane gradually enriched with EtOAc 
(0 → 100%), and then with MeOH (0 → 50%). Samples of 
200 mL were collected (44 in total) and monitored by thin 
layer chromatography (TLC) (Dragendorff’s reagent, UV 
light λ 254 nm) and combined according to their TLC profiles, 
obtaining four fractions: 1-4 (fraction I), 5-8 (fraction II), 
9-34 (fraction III) and 35-44 (fraction IV). Fraction I 
(343.4 mg) was subjected to a liquid chromatography 
column (LCC) (Ø: 1 cm) using 400 mL of n-hexane:acetone 
(1:1), 350 mL of n-hexane:acetone (1:4), 300 mL of 
n-hexane:acetone:dichloromethane (2:1:1), 250 mL of 
acetone:dichloromethane (CH2Cl2) (1:1) and 200 mL of 
acetone:CH2Cl2:MeOH (1:1:1), providing 150 samples. 
After combining samples 27-45, preparative thin layer 
chromatography (PTLC) (20 cm × 20 cm × 0.25 mm, 
silica gel F254, n-hexane:acetone:CH2Cl2 (1:1:2), v/v/v 
in NH3 atmosphere) was used to isolate trisphaeridine (2, 
18.9 mg). Fraction II (271.0 mg), was subjected to a LCC 
(Ø: 1 cm) using 150 mL of n-hexane:acetone:CH2Cl2 
(2:1:1), 200 mL of n-hexane:acetone:CH2Cl2:MeOH 
(3:3:1:2) and 250 mL acetone:MeOH (1:1), providing 
83 samples. After combining samples 14-22 and 23-83, 
PTLC (20 cm × 20 cm × 0.25 mm, silica gel F254, 
n-hexane:acetone:CH2Cl2:MeOH (3:3:1:2), v/v/v/v in NH3 
atmosphere) was used to isolate tazettine (8, 19.2 mg) and 
3-epi-macronine (13, 28.9 mg), respectively. Fraction III 
(1227.5 mg), was subjected to a LCC (Ø: 2 cm) using 
450 mL of n-hexane:AcOEt:CH2Cl2 (2:1:2), 500 mL of 
n-hexane:AcOEt:CH2Cl2:MeOH (2:1:2:1), 550 mL of 
acetone:CH2Cl2:MeOH (2:2:1) and 400 mL of acetone:MeOH 
(1:1), providing 493 samples. After combining samples 
1-93, another LCC (Ø: 1 cm) was applied using 100 mL of 
n-hexane:AcOEt (2:1), 200 mL of n-hexane:AcOEt:MeOH 
(2:4:1) and n-hexane:AcOEt:CH2Cl2:MeOH (1:2:1:1), 
providing 80 samples. After combining samples 55-79, 
PTLC (20 cm × 20 cm × 0.25 mm, silica gel F254, 
n-hexane:AcOEt:CH2Cl2:acetone:MeOH (1:2:2:1:1), 
v/v/v/v/v in NH3 atmosphere) was used to isolate 
homolycorine (12, 10.7 mg) and albomaculine (14, 15.5 mg). 
Samples 170-210, from fraction III, were subjected to 
another LCC (Ø: 1 cm) using 100 mL of n-hexane:AcOEt 
Table 1. GC-MS data for Worsleya procera, values are expressed as a relative percentage of total ion current (TIC)
Alkaloid RI
Enriched fractions / %
M+ MS
n-Hex / % EtOAc / %
Ismine (1) 2280 3.2 5.8 257(35) 238(100), 211(6), 196(8), 168(6), 154(3), 106(4), 77(3)
Trisphaeridine (2) 2282 tr tr 223(100) 222(38), 167(8), 165(9), 164(14), 138(20), 137(9), 111(13)
5,6-Dihydrobicolorine (3) 2327 tr tr 239(45) 238(100), 180(30), 166(10), 152(22), 139(21), 118(21), 90(31)
Galanthindole (4) 2487 – 12.8 281(100) 280(7), 264(13), 263(17), 262(20), 252(15), 204(7), 1(14), 132(8)
O-Methyllycorenine (5) 2492 4.0 tr 331(< 1) 300(3), 191(8), 147(1), 110(8), 109(100), 94(3), 77(1)
7-Methoxy-O-methyllycorenine (6) 2538 2.4 – 361(< 1) 330(8), 221(10), 191(2), 110(8), 109(100), 108(15), 94(2), 83(2)
Undefined - homolycorine-type derivative 2597 tr – nd 330(2), 221(5), 110(8), 109(100), 108(16), 94(5), 82(3), 42(3)
Ungwedine derivative 2598 tr tr nd 330(18), 314(10), 261(100), 239(34), 238(25), 228(31), 128(30), 
44(20)
11,12-Dehydroanhydrolycorine (7) 2606 – tr 249(60) 248(100), 190(32), 189(10), 163(10), 123(13), 95(30), 81(9)
Tazettine (8)/pretazettine (9) 2653 16.7 18.3 331(31) 316(15), 298(23), 247(100), 230(12), 201(15), 181(11), 152(7)
Galanthine (10) 2720 1.9 19.6 317(22) 316(15), 298(10), 268(18), 243(96), 242(100), 228(8)
Lycorine (11) 2746 tr 13.19 287(31) 286(19), 268(24), 250(15), 227(79), 226(100), 211(7), 147(15)
Homolycorine (12) 2767 8.9 4.8 315(< 1) 206(< 1), 178(2), 109(100), 150(1), 108(22), 94(3), 82(3)
3-epi-Macronine (13) 2811 6.10 tr 329(27) 314(23), 245(100), 225(14), 201(83), 139(16), 70(18)
Albomaculine (14) 2815 15.4 14.9 345(< 1) 221(1), 193(1), 165(1), 110(10), 109(100), 108(25), 94(2), 82(3)
Undefined - homolycorine-type derivative 2870 tr – nd 178(7), 150(4), 140(9), 138(88), 124(100), 96(14), 94(10)
Hippeastrine (15) 2917 – tr 315 (< 1) 190(1), 163(1), 134(3), 126(8), 125(100), 124(9), 96(40), 77(2)
Sterols derivatives – 3.19 – –
Neutral metabolites – 36.1 5.8 –
GC-MS: gas chromatography mass spectrometry; RI: Kovats retention indices; tr: traces (less than 1% of TIC); sterols derivatives: including stigmasterol, 
sitosterol, among others; neutral metabolites: including terpens, fatty acids, among others; nd: not detected.
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(2:1), 150 mL of n-hexane:AcOEt:acetone (4:2:1), 200 mL 
of n-hexane:acetone:CH2Cl2:MeOH (2:1:2:1), 200 mL of 
acetone:CH2Cl2:MeOH (2:1:1), 250 mL of acetone:MeOH 
(1:1) providing 113 samples. After combining samples 
22-37, PTLC (20 cm × 20 cm × 0.25 mm, silica 
gel F254, n-hexane:AcOEt:CH2Cl2:acetone:MeOH 
(1:2:2:1:1),  v/v/v/v/v in NH3 atmosphere) was 
used to isolate more homolycorine (12, 8.1 mg). 
Samples 350-420, from fraction III, were subjected 
to PTLC (20 cm × 20 cm × 0.25 mm, silica gel F254, 
AcOEt:acetone:MeOH (2:1:1), v/v/v in NH3 atmosphere) 
was used to isolate more tazettine (8, 14.6 mg). Fraction IV 
(565.4 mg) was subjected to an LCC (Ø: 2 cm) eluting with 
n-hexane gradually enriched with EtOAc (0 → 100%), and 
then with MeOH (0 → 50%), providing 285 samples. After 
combining samples 101-156, another LCC (Ø: 1 cm) was 
employed, using the same elution system as previously 
described, providing 215 samples. From samples 11-37, 
tazettine (8, 46.5 mg) was isolated again by crystallization 
with AcOEt. From samples 154-177, ismine (1, 13.1 mg) 
was isolated by precipitation, and from samples 178-202, 
more homolycorine (12, 12.8 mg) was isolated by 
precipitation.
Extract B yielded lycorine (11, 504.9 mg) by 
spontaneous precipitation. The supernatant was subjected to 
a VLCC (Ø: 5 cm) using silica gel (250 g, mesh 70/90 μm) 
eluting with n-hexane gradually enriched with EtOAc 
(0 → 100%), CH2Cl2:MeOH (1:1, 0 → 50%), and then 
with MeOH (0 → 50%). Samples of 400 mL were collected 
(35 in total) monitored by TLC (Dragendorff’s reagent, 
UV light λ 254 nm) and combined according to their TLC 
profiles, obtaining six fractions: 1-13 (fraction I), 14-18 
(fraction II), 19-25 (fraction III), 26-27 (fraction IV), 28-33 
(fraction V) and 34-35 (fraction VI). Fraction I (327.3 mg) 
was subjected to an LCC (Ø: 2 cm) using sephadex and 
MeOH as eluent obtaining 75 samples. After combining 
samples 63-75, PTLC (20 cm × 20 cm × 0.25 mm, silica 
gel F254, AcOEt:acetone:CH2Cl2:MeOH (1:1:1:1), 
v/v/v/v in NH3 atmosphere) was used to isolate ismine 
(1, 5.7 mg). No alkaloid was observed in the fraction II 
(205.0 mg). Fraction III (253.5 mg) was subjected to an 
LCC (Ø: 2 cm) using sephadex and MeOH as eluent, 
obtaining 80 samples. After combining samples 13-25, 
homolycorine was obtained (12, 8.0 mg) and samples 
64-83 were subjected to PTLC (20 cm × 20 cm × 0.25 mm, 
silica gel F254, AcOEt:acetone:CH2Cl2:MeOH (1:1:1:1), 
v/v/v/v in NH3 atmosphere) isolating trisphaeridine (2, 
7.7 mg). Fraction IV (1295.4 mg) was subjected to an 
LCC (Ø: 2 cm) using sephadex and MeOH as eluent 
obtaining 150 samples. After combining samples 64-83, 
this subfraction was subjected to an LCC (Ø: 2 cm), eluting 
with n-hexane gradually enriched with EtOAc (0 → 100%), 
CH2Cl2 and MeOH (1:1, 0 → 50%), and then with MeOH 
(0 → 50%) obtaining 350 samples. After combining 
samples 153-198, PTLC (20 cm × 20 cm × 0.25 mm, 
silica gel F254, AcOEt:acetone:CH2Cl2:MeOH = 1:1:1:1, 
v/v/v/v in NH3 atmosphere) was used to isolate tazettine 
(8, 11.5 mg) and homolycorine (12, 2.1 mg). Fraction V 
(1863.5 mg) was subjected to an LCC (Ø: 2 cm) using 
sephadex and MeOH as eluent, obtaining 250 samples. 
Samples 37-77, from fraction V, were subjected to another 
LCC (Ø: 1 cm), using 50 mL of n-hexane:AcOEt (2:1), 
200 mL of AcOEt:CH2Cl2:acetone (2:2:1), 200 mL of 
AcOEt:CH2Cl2:acetone:MeOH (2:2:1:1), 100 mL of 
acetone:MeOH (1:1) providing 110 samples. Samples 
45-77 were subjected to PTLC (20 cm × 20 cm × 0.25 mm, 
silica gel F254, AcOEt:acetone:CH2Cl2:MeOH (1:1:1:1), 
v/v/v/v in NH3 atmosphere) to obtain more tazettine (8, 
22.5 mg) and more homolycorine (12, 4.5 mg). Samples 
112-154, from fraction V, were subjected to another 
LCC (Ø: 1 cm) using 50 mL of n-hexane:AcOEt (2:1), 
200 mL of AcOEt:CH2Cl2:acetone (2:2:1), 200 mL of 
AcOEt:CH2Cl2:acetone:MeOH (2:2:1:1), 100 mL of 
acetone:MeOH (1:1) providing 110 samples. Samples 81-99 
were subjected to PTLC (20 cm × 20 cm × 0.25 mm, silica 
gel F254, AcOEt:acetone:CH2Cl2:MeOH (1:1:1:1), v/v/v/v 
in NH3 atmosphere) to obtain more thisphaeridine (2, 
2.2 mg). Samples 155-201, from fraction V, was subjected 
to another LCC (Ø: 1 cm) using 50 mL of n-hexane:AcOEt 
(2:1), 200 mL of AcOEt:CH2Cl2:acetone (2:2:1), 200 mL 
of AcOEt:CH2Cl2:acetone:MeOH (2:2:1:1), 100 mL of 
acetone:MeOH (1:1) providing 110 samples. From samples 
82-101, it was observed a precipitate identified as ismine 
(1, 5.0 mg). No alkaloid was observed in the fraction VI 
(1060.6 mg) and extract C. All isolated alkaloids were 
identified by comparing their spectroscopy data with those 
of alkaloids previously isolated and characterized described 
in literature.27,28,30-34
X-ray experimental data
X-ray intensity data were collected on a Bruker AXS 
Proteum X8 diffractometer using ϕ and ω scans. The 
diffractometer was equipped with a Cu FR591 rotating 
anode and multilayer X-ray optics. An Oxford Cryosystems 
700 controller was used to keep the temperature at 100 K 
during data collection. The APEX235 software was used to 
operate the diffractometer and planning the data collection 
strategy. The data were integrated using SAINT36 program 
and the correction for absorption effects was made using 
Gaussian numerical integration and scaled with SADABS37 
program.
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The crystal structure of tazettine (8) was solved by 
direct methods using the SHELXS38 program and refined 
by full-matrix least-squares method against the intensity 
data using SHELXL38 program. Anisotropic displacement 
parameters (ADP) were applied for all non-hydrogen 
atoms. Hydrogen atoms were observed by Fourier 
maps, and placed at geometrically calculated positions 
and refined using an appropriate riding model regard to 
the parent atom with Uiso(H) = 1.2Ueq(C), displacement 
parameters, while the hydroxyl and methyl group were 
set using Uiso(H) = 1.5Ueq(O, Cmethyl). The solving and 
refinement were made with aid of the Olex239 program. 
The structure representations were done by ORTEP-340 and 
MERCURY41 programs. The crystallographic information 
and the structure data files for tazettine are deposited at 
Cambridge Crystallographic Data Centre (Supplementary 
Information section).
P. falciparum in vitro culture and in vitro SYBR green assay
The inhibitory activity of the seven isolated alkaloids 
and three extracts was evaluated against P. falciparum 
blood parasites of the 3D7 (chloroquine sensitive) and K1 
(multidrug-resistant to the antimalarial drugs chloroquine, 
pyrimethamine and cycloguanil) strains. An aliquot of the 
3D7 or K1 strain was obtained from the Malaria Research 
and Reference Reagent Resource Center (MR4-BEI 
Resources) and cultured as previously described,42 using 
complete RPMI medium (RPMI 1640 medium supplemented 
with 25 mM hepes (pH 7.4), 21 mM sodium bicarbonate, 
11 mM D-glucose, 3.67 mM hypoxanthine, 40 μg mL-1 of 
penicillin-streptomycin and 0.5% (m/v) Albumax®). The 
compounds were previously solubilized in 0.05% dimethyl 
sulfoxide (DMSO) (v/v), distributed in duplicate in 96-well 
plates, using two-fold serial dilutions in complete RPMI 
medium to assay a range of concentrations (10-0.152 μM or 
10-0.152 μg mL-1). Synchronous ring-stage cultures of the 
parasite were added to the plate to a final parasitemia of 0.5% 
and hematocrit of 2%. Previous ring-stage synchronization 
was performed by the sorbitol method.43 
Each 96-well plate included positive and negative 
control wells, consisting of infected red blood cells 
without test compounds and non-infected red blood cells, 
respectively. Artesunate was used in each experiment 
as an antimalarial positive control. All compounds were 
tested in duplicate in two independent experiments. The 
effects of the samples on parasite growth were measured 
through the SYBR® green assay.44 Briefly, the medium 
was removed, followed by addition of 1X PBS (phosphate 
buffered saline) and incubation for 30 min with lysis buffer 
solution [TRIS, ultra-pure 20 mM, pH 7,5; EDTA 5 mM 
ultrapure; Saponin 0.008% m/v; Triton X-100 0.08% v/v; 
water Type I] and SYBR® green I DNA stain (in a 1:20000 
dilution). Fluorescence was aquired on a fluorimeter 
(SpectraMax 340 PC 384) at 485/535 nm. The fluorescence 
of each well was used to calculate the normalized viability 
in comparison to the positive (100% viability) and negative 
(0% viability) control wells. The half-maximal sample 
inhibitory concentration (IC50) was estimated by curve 
fitting using software from the OriginLab Corporation 
(USA) and comparing to the parasite growth in the 
drug-free medium. The reported antiplasmodial activities 
(Tables 2 and 3) are the mean values of two independent 
experiments. The assessed IC50 values are based on the mass 
of the isolated compounds or extracts dissolved in DMSO. 
Cytotoxicity tests using immortalized liver cells by MTT 
assay 
The cytotoxicity of the all samples was evaluated in a 
human hepatoma cell line (HepG2, obtained from American 
Type Culture Collection (ATCC; Manassas, VA, USA)) using 
cells cultured in 75 cm2 sterile flasks containing RPMI-1640 
medium (supplemented with 10% heat-inactivated fetal bovine 
serum and 40 mg L-1 gentamicin) under a 5% CO2 humidified 
atmosphere at 37 °C. When confluent, the cell monolayer 
was washed with culture medium, trypsinized, distributed 
in a flat-bottomed 96-well plate (5 × 104 cells per well) 
and incubated for 24 h at 37 °C for cell adherence (method 
adapted from Denizot and Lang).45 The samples (20 μL) at 
various concentrations (400-0.5 μM or 400-0.5 μg mL-1 in 
two-fold serial dilutions) were placed in the 96-well plates, 
incubated with the cultured cells for 24 h under a 5% CO2 
atmosphere at 37 °C, and then the 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide (MTT) solution 
(5 mg mL-1; 20 μL per well for 3 h) was used to evaluate the 
mitochondrial viability. Each plate included positive control 
wells without addition of test compounds. The supernatants 
were carefully removed and 100 μL of DMSO were added 
to each well and mixed to solubilize the formazan crystals. 
The optical density was determined at 570 nm. The cell 
viability was expressed as the percentage of the control 
absorbance in the untreated cells after subtracting the 
appropriate background. The reported cytotoxic potency 
(Table 3) is the mean value of two independent experiments.
Results and Discussion
Chemical analysis of alkaloids
Lycorine (11) was the major alkaloid obtained 
(547.2 mg, 0.37% m/m) followed by tazettine (8, 114.3 mg, 
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0.08% m/m), homolycorine (12, 33.4 mg, 0.02% m/m), 
3-epi-macronine (13, 28.9 mg, 0.02% m/m), trisphaeridine 
(2, 28.8 mg, 0.02%), ismine (1, 23.8 mg, 0.02% m/m) and 
albomaculine (14, 15.5 mg, 0.01%).
The GC-MS approach applied to enriched-alkaloidal 
fractions from Worsleya procera (Table 1) allowed us 
to distinguish 18 alkaloids from the complex mixture 
of metabolites, been that 15 of them were identified by 
comparison of their GC-MS spectra and Kovats retention 
indices with our in-home library database (Figure 1). 
The alkaloids pretazettine (expressed as tazettine) and 
albomaculine were the main components from the n-Hex 
extract, while galanthine and again pretazettine were the 
major alkaloids from the EtOAc extract. The observed 
percentages in both extracts were approximately 15 
and 20% of TIC (total ion current). The labile alkaloid 
pretazettine undergoes a fast rearrangement to tazettine 
after acid-base extraction and under GC-MS conditions, and 
then it is detected as tazettine.29 Lycorine and galanthindole 
showed a remarkable percentage at the EtOAc extract (13.2 
and 12.8%, respectively), although it showed no detection 
and less than 1% of TIC from n-Hex fraction, respectively. 
Homolycorine, which is biogenetically related with the 
lycorine skeleton, displayed 8.9 and 4.8% of TIC from 
n-Hex and EtOAc fractions, respectively. The alkaloids 
3-epi-macronine showed 6.1% of TIC from n-Hex extract, 
although it was detected only as traces from EtOAc fraction.
Concerning the minor components, the considered 
catabolic product from haemanthamine-type skeleton 
ismine was detected from the n-Hex extract at percentages 
of 3.2 and 5.8% of TIC, respectively. The related 
homolycorine-type alkaloid O-methyllycorenine was only 
detected from n-Hex extract, but at low amount (4.0%). The 
alkaloids belonging to the homolycorine series displaying a 
typical EI-MS fragmentation pattern which is featured by a 
retro-Diels-Alder rearrangement generated two fragments: 
one, the most representative, illustrates the pyrrolidine ring 
(along with the substituents in position 2), and the other 
one (a less abundant fragment) encompasses the aromatic 
lactone or hemilactone moiety.46 Furthermore, a noteworthy 
feature is the low abundance of the molecular ion peak in 
all alkaloids with a double bound Δ.3,4 In this attempt, some 
alkaloids were detected belonging to the homolycorine-type 
skeleton, even though they were not identified using only 
GC-MS techniques. Besides, an ungwedine derivative was 
detected by GC-MS, but just as traces. Further efforts must 
be applied in terms of collection of plant material, acid-base 
extraction and purification steps for isolation of these minor 
components and complete structure characterization using 
other spectroscopic techniques.
X-ray analysis
During the work with the isolation of Worleya procera 
chemical compounds, tazettine (8) crystallized 
spontaneously. This led us to an in-depth study on the 
crystallographic structure of this compound.
A single-crystal X-ray diffraction experiment of 
tazettine (8) was carried out to determine the absolute 
configuration of the molecule. In this sense, we initially 
carried out a low temperature single crystal X-ray diffraction 
experiment using Cu radiation. The crystallographic 
structure of the compound 8 is already known. However, 
structure was reported with error on absolute-configuration 
Figure 1. Alkaloids identified in Worsleya procera.
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in 199647 because no accurate experiment was carried 
out. Then in 1998,48 a more rigorous experiment at low 
temperature was reported, giving, therefore, a more 
accurate structure. In this work, the structural determination 
was conducted at 178 K, facilitating the scattering and 
allowing a more reliable absolute structure determination. 
Indeed, Linden et al.48 refined their structure based on the 
comparison with the derivative N-methyltazettine iodide,49 
once no meaningful anomalous scattering was observed for 
tazettine compound using Mo radiation.
Therefore, here we performed a meticulous experiment 
with Cu radiation at lower temperature (100 K) to avoid 
the hitch of the non-anomalous scattering observation in 
tazettine. This strategy allowed us to obtain well-defined 
Friedel pairs suitable to solve the absolute configuration 
with a coherent Flack parameter.50,51 It is important 
to mention that for a meaningful absolute structure 
characterization, the Flack parameter should be close to 
0 (with significant errors also) when the correct absolute 
configuration over each chiral center is given correctly.
Regarding the molecular conformation, an S-configuration 
was observed in each chiral center during the refinement. In 
this way, the structure reported herein matches very well with 
the one reported by Linden et al.,48 with a very low root mean 
square deviation value (RMS 0.00681). As discussed by 
Linden et al.,48 all the structural parameters are in a normal 
range of expected values. The small differences between 
both structures are mainly due to the differences in the data 
collection temperature. The hydroxyl group (C6a−O6a) 
exhibits a bond length of 1.400(3) Å, which is a value lower 
than the expected for hydroxyl groups linked to a sp3-carbon 
atom.52 Asymmetrical C−N bonds were also observed 
over the N-atom which adopts a sp3-pyramidalization, as 
pointed out Linden et al.48 Meanwhile, the bond vector of 
the methoxy group (O3−C14) showed an anti-orientation 
regarding the hydroxyl group, which was settled by the 
torsional angles C2−C3−O3−C14 and C4−C3−O3−C14 
(−171.75° and 66.57°, respectively).
Both the cyclohexene and the pyran rings exhibited 
distorted half-chair conformations. The cyclohexene 
ring was twisted over the C4−C4a bond, while the pyran 
ring was twisted over the C6a−O7 bond. The pyrrolidine 
ring also showed a half-chair conformation twisted on 
C6a−C13b bond. Lastly, the 1,3-benzodioxole ring showed 
an almost planar conformation, except for the position of 
the C11 atom, which was slightly deviated (0.20 Å) from 
the mean plane of the remaining atoms. An ORTEP type 
view model of tazettine asymmetric unit showing the 
atom-labelling and an overlay of the tazettine structure 
described here with one reported structure by Linden et al.48 
(red) can be seen in Figures 2a and 2b, respectively.
Tazettine crystallized in the non-centro symmetric 
orthorhombic space group P212121. The hydroxyl group 
acted as a donor center of strong OH•••O hydrogen-bonds 
with the methoxy groups of adjacent molecules along the 
crystallographic b axes, giving raise to one-dimensional 
infinite chains with C(8) graph set.53 We observed weak 
C−H•••N interactions between one C−H fragment of 
benzodioxole group and the sp3-pyramidal N atoms and 
could contribute to the crystal packing. Additionally, π•••π 
interactions between the 1,3-benzodioxole fragments 
helped in the stacking of the tazettine molecules along 
the crystallographic a axe. A stereographic view from the 
crystal packing and the main intermolecular interactions 
of tazettine crystal packing can be seen in the Figures 3 
and 4, respectively.
Biological activity
Many compounds found in Amaryllidaceae plants have 
antiplasmodial potential,10 and therefore, we assessed the 
biological relevance of the Worsleya procera root extracts 
by investigating the antiplasmodial potency of the samples. 
Thus, a total of 10 samples was tested against P. falciparum 
(3D7 strain, sensitive to chloroquine), including three 
extracts (A-C) and seven isolated compounds. The 
hexane (extract A) and ethyl acetate (extract B) fractions 
were active against the parasite, showing IC50 values of 
1.3 and 0.8 μg mL-1, respectively (Table 2), whereas the 
EtOAc:MeOH fraction (extract C) was inactive under the 
assay condition. Next, we assessed the parasite growth 
inhibitory activity of the seven major isolated alkaloids 
to identify which extract components were related to 
the antiplasmodial activity (Table 3). We set a threshold 
concentration value of 10 μM to identify the active 
compounds. Based on that, lycorine was the most potent 
P. falciparum inhibitor, with inhibitory activity in the low 
Figure 2. (a) ORTEP type view model of tazettine asymmetric unit 
showing the atom-labelling Thermal displacement ellipsoids are drawn 
at 50% probability level. Hydrogens atoms are drawn with arbitrary 
radii; (b) overlay of the tazettine structure (blue) described here with one 
reported structure by Linden et al.48 (red). Hydrogen atoms were omitted 
for the sake of clarity. The CSD ref. code RENRIL01 was assigned for 
the Linden et al.48 structure.
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micromolar range (IC50 value of 2.5 μM) (Table 3). This 
result is in agreement with previous data.10 Furthermore, 
lycorine was tested against the P. falciparum K1 strain 
(resistant to chloroquine, cycloguanil and pyrimethamine) 
to evaluate potential cross-resistance of the compound. As 
indicated in Table 3, the IC50 values against both sensitive 
and resistant strains were similar, thereby suggesting that 
lycorine’s mechanism of action is distinct from those related 
to the K1 strain resistance. 
Aiming to verify whether the antiplasmodial activities 
were related to cytotoxic effect, we evaluated the 
cytotoxicity of the active samples against HepG2 cells 
(hepatic human cells). A selectivity index (SI) above 
10 generally indicates that the sample is well-tolerated by 
the cell. Interestingly, lycorine (EC50 > 400 μM) (median 
effective dose (EC50)), as well as the ethyl acetate and 
hexane extracts (both with EC50 > 400 μg mL-1) were not 
cytotoxic under the experimental conditions, showing 
high selectivity indexes (SI values > 129 > 300 and > 500, 
respectively) (Tables 2 and 3).
The Worsleya procera (Lem.) Traub is yet largely 
unexplored in terms of chemical diversity. In this 
work, we showed that the roots of this plant contain 
compounds identified in other members of its family, 
such as Lycoris radiata. The Amaryllidaceae family of 
plants is of particular pharmacological interest in the 
field of natural products for the characteristic production 
of isoquinolinic alkaloids, a series of compounds with 
confirmed antitumoral, antimalarial and anti-inflammatory 
activity, among others.54 Other compounds obtained from 
this family are the cripowellins, isolated from plants of 
the Crinum genus, which have presented antiplasmodial 
potency in the nanomolar range,55 providing further 
evidence to the potential of these plants as a source of 
compounds with promising antiplasmodial activity.
Figure 3. Stereographic view from the crystal packing along the (a) a 
axis and (b) 1836655 axes; hydrogens atoms were omitted for the sake 
of clarity.
Figure 4. Main intermolecular interactions of tazettine crystal packing: (a) unidimensional hydrogen-bond chain along the crystallographic b axe; (b) weak 
interaction of C−H•••N type, and (c) π-stacking of the 1,3-benzodioxole groups along the crystallographic a axe.
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Conclusions
Fifteen alkaloids were identified from the roots of the 
native species Worsleya procera, and seven of them were 
isolated. We obtained a crystal of the compound tazettine, 
and a detailed X-ray analysis was performed to obtain the 
unequivocal absolute configuration of this compound. The 
fractions and isolated compounds were tested in vitro against 
Plasmodium falciparum, and the compound lycorine showed 
antiplasmodial activity against sensate and resistant strains 
(IC50 values of 2.5 and 3.1 μM, respectively). Moreover, 
the compound showed a low cytotoxicity profile, with a 
selectivity index greater than 100. Our findings indicate that 
lycorine is a hit for antimalarial drug discovery.
Supplementary Information
Crystallographic data (excluding structure factors) for 
the structures in this work were deposited in the Cambridge 
Crystallographic Data Centre as supplementary publication 
number CCDC 1836655. Copies of the data can be obtained, 
free of charge, via www.ccdc.cam.ac.uk/conts/retrieving.
html or from the Cambridge Crystallographic Data Centre, 
CCDC, 12 Union Road, Cambridge CB2 1EZ, UK; fax: +44 
1223 336033. E-mail: deposit@ccdc.cam.ac.uk.
Supplementary information (NMR spectra, biological 
data and crystallographic parameters of tazettine) is available 
free of charge at http://jbcs.sbq.org.br as a PDF file.
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